Cutting edge approaches to detecting brain mosaicism associated with common focal epilepsies: implications for diagnosis and potential therapies
Journal Title
Expert Review of Neurotherapeutics
Publication Type
epub ahead of print
INTRODUCTION: Mosaic variants arising in brain tissue are increasingly being recognized as a hidden cause of focal epilepsy. This knowledge gain has been driven by new, highly sensitive genetic technologies and genome-wide analysis of brain tissue from surgical resection or autopsy in a small proportion of patients with focal epilepsy. Recently reported novel strategies to detect mosaic variants limited to brain have exploited trace brain DNA obtained from cerebrospinal fluid liquid biopsies or stereo-electroencephalography electrodes. AREAS COVERED: The authors review the data on these innovative approaches published in PubMed before June 12, 2021, discuss the challenges associated with their application, and describe how they are likely to improve detection of mosaic variants to provide new molecular diagnoses and therapeutic targets for focal epilepsy, with potential utility in other non-malignant neurological disorders. EXPERT OPINION: These cutting-edge approaches may reveal the hidden genetic aetiology of focal epilepsies and provide guidance for precision medicine. (150/150 words).
CSF liquid biopsy; brain lesion; focal epilepsy; high-depth exome sequencing; somatic mosaicism; stereo-electroencephalography
WEHI Research Division(s)
Population Health And Immunity
PubMed ID
Terms of Use/Rights Notice
Refer to copyright notice on published article.

Creation Date: 2021-09-17 11:23:26
Last Modified: 2021-09-17 12:01:25
An error has occurred. This application may no longer respond until reloaded. Reload 🗙